Burning mouth syndrome (BMS) is a chronic condition characterized by a burning pain in the mouth, sometimes accompanied by numbness. The clinical features of this condition closely resemble other ...

Bristol Myers Squibb (BMS) agreed to acquire Mirati Therapeutics for up to $5.8 billion, in a deal that expands the buyer’s cancer portfolio.

BMS' Breyanzi is the first CAR-T drug to deliver a positive readout in CLL in a pivotal multicenter study. Still, its path at the FDA remains uncertain.

The FDA has issued a safety alert for specific batches of Great Value frozen raw shrimp sold at Walmart, after U.S. Customs detected Cesium-137, a radioactive isotope, in shipments from Indonesia's ...

Hyundai claimed BMS can help prevent battery fires by notifying EV owners and the automakers’ support centres of any battery abnormalities such as overcharging and micro short circuits.